Genetic testing doesn't treat sexual dysfunction — it maps the biological terrain that every treatment decision operates within. The Precision Peptide Genetic Test delivers 6 Sexual Health insights across 14 pathways, 49 peptides, and 150+ genetic insights, giving providers the upstream biological context that bloodwork alone cannot supply — and changing the clinical conversation before any protocol begins.

In the Precision Peptide Genetic Test, the Sexual Health pathway delivers 6 insights across the genes governing central arousal, vascular sexual response, desire, bonding, and circadian sexual timing. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 6 variants map sexual biology as a connected system — not a checklist of isolated traits.

PDE5 pathway support compounds work differently for different men because the upstream signal they amplify — eNOS-derived nitric oxide — is genetically variable. NOS3 genotype sets the vascular floor. The Precision Peptide Genetic Test maps this and other pathway variables across 14 pathways, 49 peptides, and 150+ genetic insights, explaining the response variability that dosing alone cannot.

Yes — eNOS genetics directly shapes the nitric oxide foundation that vascular sexual response is built on. NOS3 variants determine how much NO your endothelium produces per arousal signal. The Precision Peptide Genetic Test analyzes eNOS variants as part of 14 pathways, 49 peptides, and 150+ genetic insights, answering the question bloodwork alone cannot.

Erectile function depends on multiple gene-governed systems — nitric oxide production, central arousal signaling, dopamine-driven desire, and cGMP preservation. The Precision Peptide Genetic Test maps the key variants across 14 pathways, 49 peptides, and 150+ genetic insights, identifying the genetic architecture that testosterone panels and vascular tests alone cannot reveal.

Sexual wellness has a genetic architecture — six biological variables that determine how your body produces arousal, routes blood flow, generates desire, and responds to intimacy. The Precision Peptide Genetic Test maps all six as part of 14 pathways, 49 peptides, and 150+ genetic insights, answering the question that hormone panels and bloodwork alone cannot.

The vasoactive pathway governs genital blood flow through multiple parallel mechanisms — nitric oxide, prostaglandin signaling, and alpha-adrenergic tone — each with its own genetic variable. The Precision Peptide Genetic Test maps key vasoactive pathway variants as part of 14 pathways, 49 peptides, and 150+ genetic insights, revealing the full vascular architecture that sexual arousal depends on.

PDE5 pathway support works differently for different people — and genetics is one of the most direct explanations for that variability. The Precision Peptide Genetic Test maps upstream NOS3 and downstream pathway variables as part of 14 pathways, 49 peptides, and 150+ genetic insights, explaining the vascular dimension of differential response.

eNOS — the endothelial nitric oxide synthase enzyme encoded by NOS3 — is the genetic starting point of the vascular cascade that sexual arousal depends on. The Precision Peptide Genetic Test analyzes NOS3 variants as part of 14 pathways, 49 peptides, and 150+ genetic insights, mapping the upstream NO signal before it reaches the PDE5 pathway.